NEWS

• Randall L Morrison et al.: Effect of Esketamine Nasal Spray on Cognition in Patients with Treatment-Resistant Depression: Results from Four Phase-3 Studies. Read HERE
  
  

• Zhang, Fang-fang et al.: Upregulation of Phosphodiesterase 7A Contributes to Concurrent Pain and Depression via Inhibition of cAMP-PKA-CREB-BDNF Signaling and Neuroinflammation in the Hippocampus of Mice. Read HERE
  
  

• Katharina Domschke et al.: Epigenome-Wide DNA Methylation in Unipolar Depression: Predictive Biomarker of Antidepressant Treatment Response? Read HERE
  

CINP President, Kazutaka Ikeda, visited the Philippines from September 24 to 27, delivering two lectures and engaging with leaders in the Philippine neuropsychopharmacology community.

We are delighted that our Philippine colleagues agreed to organize two sessions for the CINP-AsCNP 2025 congress in Melbourne in June 2025. 

This visit underscores CINP's commitment to fostering global collaboration and strengthening ties with national scientific societies.

Read the full report HERE

As part of our mission ‘advancing worldwide neuroscience and education for brain and mental health’, CINP is committed to bringing opportunities for networking and education to all members of our global community.

One of the most important ways in which we can achieve this is by rotating the World Congress to allow scientists and clinicians from all over the world to attend this prestigious event in person and we believe that our members have an important role to play in this process.

We are therefore now seeking applications from CINP members to host CINP2027 – the 38th World Congress of Neuropsychopharmacology.

Read more

We are delighted to present the Editor’s Picks - a new regular series of featured articles from the International Journal of Neuropsychopharmacology.

• Weiss, Emily R.: Metabotropic glutamatergic receptor 5 as a potential biomarker of the intersection of trauma and cannabis use. Read HERE
  
  
• Nicholas E Bulthuis: GluN2B on Adult-Born Granule Cells Modulates (R,S)-Ketamine’s Rapid-Acting Effects in Mice. Read HERE
  
  
• Gang Wang: GluN2A: A Promising Target for Developing Novel Antidepressants. Read HERE
  
  

Watch the recent CINP Webinars online: 

Prof. Geraldine Dawson:

Digital Health Approaches to the Early Detection of Autism

Watch here

Precision in Psychopharmacology: Is There Room for Neuroscience-based Nomenclature (NbN) in Clinical Practice?

Watch here

Prof. Stefano Pallanti: 
TMS: Basic Principles, Clinical Uses, and Research Principles

Watch here

The highlights of the 35th World Congress in Neuropsychopharmacology in Tokyo are now available to watch.

From June 2nd to 8th, CINP participated in the AfCNP School of Neuropsychopharmacology of Stress and Substance Use Disorder which took place in Nairobi, Kenya.

The CINP support evolved by sending a faculty member (Prof. Zohar, the immediate Past President) to this event.

Along with faculty supported by ACNP, NIH, and Aga Khan University to name a few. This multi-organization collaboration led to a very successful interactive course with participants from all over Africa.

CINP will continue to look for future activities in order to actively move the CINP mission Advancing worldwide neuroscience and education for mental health into action.

Prof. Gabriella Gobbi, CINP President-Elect, and Prof.  Joseph Zohar, CINP Past-President, represented the CINP during the Congress on Brain, Behavior and Emotions 2024 Congress in Rio de Janeiro, Brazil, from 26 to 29 June.

Prof. Gobbi shared her experience and details of the planned collaboration between the CINP and this important event.

Read the full report here.

Get to know the CINP Executive Committee members and Councillors. 

Read bios of the Executive Committee members here

Read bios of the Councillors here

Dear fellow CINP members,
It is a great honor to be appointed as the CINP President. For 67 years, CINP has been at the forefront of neuropsychopharmacology worldwide. I want to express my deepest gratitude to the current and past members for their invaluable contributions.

Read more